Functional foods and dietary supplements: Products at the interface between pharma and nutrition

European Journal of Pharmacology

Volumn 668, Issue SUPPL. 1, 2011, Pages

  Eussen, Simone R B M ^a,b   Verhagen, Hans ^a,c,d   Klungel, Olaf H ^b   Garssen, Johan ^b   Van Loveren, Henk ^a,c   Van Kranen, Henk J ^a   Rompelberg, Cathy J M ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Claim; Dietary supplement; EU regulation; Food pharma; Functional food; Pharma nutrition

Indexed keywords

CALCIUM; DOCOSAHEXAENOIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; MEVINOLIN; NATURAL PRODUCT; OMEGA 3 FATTY ACID; THALIDOMIDE;

BLOOD PRESSURE REGULATION; CALCIUM INTAKE; CARDIOVASCULAR DISEASE; CONCEPTUAL FRAMEWORK; CONFERENCE PAPER; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIET SUPPLEMENTATION; DRUG ACTIVITY; DRUG EFFICACY; EDUCATIONAL TECHNOLOGY; EVIDENCE BASED MEDICINE; FOOD DRUG INTERACTION; FOOD SAFETY; FUNCTIONAL FOOD; HEALTH BEHAVIOR; HEALTH CARE COST; HEALTH HAZARD; HOMEOSTASIS AND REGULATION; HUMAN; HYPERTENSION; LAW; LIFESTYLE; OSTEOPOROSIS; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REGULATORY MECHANISM; RISK BENEFIT ANALYSIS;

BIOMEDICAL TECHNOLOGY; DIETARY SUPPLEMENTS; FUNCTIONAL FOOD; HUMANS; MEDICINE; NUTRITIONAL SCIENCES; PHARMACEUTICAL PREPARATIONS;

EID: 80055029175     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.07.008     Document Type: Conference Paper

References (101)

1. M. Abad, L. Bedoya, and P. Bermejo An update on drug interactions with the herbal medicine Ginkgo biloba Curr. Drug Metab. 11 2010 171 181
2. L. Afman, and M. Müller Nutrigenomics: from molecular nutrition to prevention of disease J. Am. Diet. Assoc. 106 2006 569 576
3. A. Alevizos, C. Mihas, and A. Mariolis Advertising campaigns of sterol-enriched food. An often neglected cause of reduced compliance to lipid lowering drug therapy. Cardiovasc. Drugs Ther. 21 2007 133 134 (Pubitemid 46834908)
4. A. Baeyens, and T. Goffin ECJ 2009/02 Hecht-Pharma GmbH v. Staatliches Gewerbeaufsichtsamt Lüneburg and Vertreterin des Bundesinteresses beim Bundesverwaltungsgericht, 15 January 2009 (C-140/07) Eur. J. Health Law 16 2009 197 200
5. S.L. Booth, and M.A. Centurelli Vitamin K: a practical guide to the dietary management of patients on warfarin Nutr. Rev. 57 1999 288 296 (Pubitemid 29514067)
6. J.F. Borel, F. Di Padova, J. Mason, V. Quesniaux, B. Ryffel, and R. Wenger Pharmacology of cyclosporine (sandimmune). I. Introduction. Pharmacol. Rev. 41 1990 239 242 (Pubitemid 20129962)
7. F. Borrelli, and A. Izzo Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations AAPS J. 11 2009 710 727
8. R.H. Bradford, C.L. Shear, A.N. Chremos, C.A. Dujovne, F.A. Franklin, R.B. Grillo, J. Higgins, A. Langendorfer, D.T. Nash, and J.L. Pool Expanded Clinical Evaluation of Lovastatin (EXCEL) study results: two-year efficacy and safety follow-up Am. J. Cardiol. 74 1994 667 673
9. D.D. Brown, R.P. Juhl, and S.L. Warner Decreased bioavailability of digoxin due to hypocholesterolemic interventions Circulation 58 1978 164 172 (Pubitemid 8376675)
10. C.P. Cannon Combination therapy in the management of mixed dyslipidaemia J. Intern. Med. 263 2008 353 365 (Pubitemid 351342686)
11. C.T. Caskey Using genetic diagnosis to determine individual therapeutic utility Annu. Rev. Med. 61 2010 1 15
12. C. Colalto Herbal interactions on absorption of drugs: mechanisms of action and clinical risk assessment Pharmacol. Res. 62 2010 207 227
13. P. Coppens, L. Delmulle, O. Gulati, D. Richardson, M. Ruthsatz, H. Sievers, and S. Sidani Use of botanicals in food supplements. Regulatory scope, scientific risk assessment and claim substantiation Ann. Nutr. Metab. 50 2006 538 554 (2005) (Pubitemid 46218888)
14. P. Coppens, M. da Silva, and S. Pettman European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety Toxicology 221 2006 59 74 (Pubitemid 43325007)
15. A. Dahan, and H. Altman Food-drug interaction: grapefruit juice augments drug bioavailability-mechanism, extent and relevance Eur. J. Clin. Nutr. 58 2004 1 9 (Pubitemid 38159306)
16. N. de Jong, O.H. Klungel, H. Verhagen, M.C. Wolfs, M.C. Ocke, and H.G. Leufkens Functional foods: the case for closer evaluation BMJ 334 2007 1037 1039 (Pubitemid 46808452)
17. N. de Jong, M.M. Ros, M.C. Ocke, and H. Verhagen A general postlaunch monitoring framework for functional foods tested with the phytosterol/-stanol case Trends Food Sci. Technol. 19 2008 535 545
18. EFSA Plant Sterols and Blood Cholesterol - Scientific substantiation of a health claim related to plant sterols and lower/reduced blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006 (Available from:) http://www.efsa.europa.eu/en/efsajournal/ doc/781.pdf 2008 (Accessed 3 March 2011)
19. EFSA Plant stanol esters and blood cholesterol - Scientific substantiation of a health claim related to plant stanol esters and lower/reduced blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006 (Available from:) http://www.efsa.europa.eu/en/efsajournal/doc/825.pdf 2008 (Accessed 3 March 2011)
20. EFSA Xylitol chewing gum/pastilles and reduction of the risk of tooth decay - Scientific substantiation of a health claim related to xylitol chewing gum/pastilles and reduction the risk of tooth decay pursuant to Article 14 of Regulation (EC) No 1924/2006 (Available from:) http://www.efsa.europa.eu/en/ efsajournal/doc/852.pdf 2008 (Accessed 3 March 2011)
21. EFSA ALA and LA and growth and development of children - Scientific substantiation of a health claim related to α-linolenic acid and linoleic acid and growth and development of children pursuant to Article 14 of Regulation (EC) No 1924/2006 (Available from:) http://www.efsa.europa.eu/en/efsajournal/ doc/783.pdf 2008 (Accessed 3 March 2011)
22. EFSA Calcium and vitamin D and bone strength - Scientific substantiation of a health claim related to calcium and vitamin D and bone strength pursuant to Article 14 of Regulation (EC) No 1924/2006 (Available from:) http://www.efsa.europa.eu/en/efsajournal/doc/828.pdf 2008 (Accessed 3 March 2011)
23. EFSA Calcium and bone growth - Scientific substantiation of a health claim related to calcium and bone growth pursuant to Article 14 of Regulation (EC) No 1924/2006 (Available from:) http://www.efsa.europa.eu/en/efsajournal/ doc/826.pdf 2008 (Accessed 3 March 2011)
24. EFSA Vitamin D and bone growth - Scientific substantiation of a health claim related to vitamin D and bone growth pursuant to Article 14 of Regulation (EC) No 1924/2006 (Available from:) http://www.efsa.europa.eu/en/efsajournal/ doc/827.pdf 2008 (Accessed 3 March 2011)
25. EFSA Dairy fresh cheese and bone growth - Scientific substantiation of a health claim related to dairy fresh cheese and bone growth pursuant to Article 14 of Regulation (EC) No 1924/2006 (Available from:) http://www.efsa.europa.eu/ en/efsajournal/doc/895.pdf 2008 (Accessed 3 March 2011)
26. EFSA Animal protein and bone growth - Scientific substantiation of a health claim related to animal protein and bone growth pursuant to Article 14 of Regulation (EC) No 1924/2006 (Available from:) http://www.efsa.europa.eu/en/ efsajournal/doc/858.pdf 2008 (Accessed 3 March 2011)
27. EFSA Plant Stanols and Plant Sterols and Blood LDL-Cholesterol - Scientific Opinion on a request from the European Commission and a similar request from France in relation to the authorization procedure for health claims on plant stanols and plant sterols and lowering/reducing blood LDL-cholesterol pursuant to Article 14 of Regulation (EC) No 1924/2006 (Available from:) http://www.efsa.europa.eu/en/efsajournal/doc/1175.pdf 2009 (Accessed 3 March 2011)
28. EFSA Danacol® and blood cholesterol Scientific substantiation of a health claim related to a low fat fermented milk product (Danacol®) enriched with plant sterols/stanols and lowering/reducing blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006 (Available from:) http://www.efsa.europa.eu/en/efsajournal/doc/1177. pdf 2009 (Accessed 3 March 2011)
29. EFSA Scientific Opinion on the Substantiation of a health claim related to Iodine and the growth of children pursuant to Article 14 of Regulation (EC) No 1924/2006 (Available from:) http://www.efsa.europa.eu/en/efsajournal/doc/ 1359.pdf 2009 (Accessed 3 March 2011)
30. EFSA Scientific Opinion on the Substantiation of a health claim related to Iron and cognitive development of children pursuant to Article 14 of Regulation (EC) No 1924/2006 (Available from:) http://www.efsa.europa.eu/en/ efsajournal/doc/1360.pdf 2009 (Accessed 3 March 2011)
31. EFSA Water-soluble tomato concentrate (WSTC I and II) and platelet aggregation [1] (Available from:) http://www.efsa.europa.eu/en/efsajournal/doc/ 1101.pdf 2009 (Accessed 3 March 2011)
32. EFSA Scientific Opinion on the substantiation of health claims related to EPA, DHA, DPA and maintenance of normal blood pressure (ID 502), maintenance of normal HDLcholesterol concentrations (ID 515), maintenance of normal (fasting) blood concentrations of triglycerides (ID 517), maintenance of normal LDL-cholesterol concentrations (ID 528, 698) and maintenance of joints (ID 503, 505, 507, 511, 518, 524, 526, 535, 537) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (Available from:) www.efsa.europa.eu/en/scdocs/doc/s1263.pdf 2009 (Accessed 3 March 2011)
33. EFSA Guidance on human risk-benefit assessment of foods (Available from:) http://www.efsa.europa.eu/en/scdocs/doc/1673.pdf 2010 (Accessed 3 March 2011)
34. EFSA Scientific Opinion on the modification of the authorisation of a health claim related to water-soluble tomato concentrate and helps to maintain a healthy blood flow and benefits circulation pursuant to Article 13(5) of Regulation (EC) No 1924/2006 following a request in accordance with Article 19 of the Regulation (EC) No 1924/2006 (Available from:) http://www.efsa.europa.eu/ en/scdocs/doc/1689.pdf 2010 (Accessed 3 March 2011)
35. EFSA Scientific Opinion in relation to the authorisation procedure for health claims on calcium and vitamin D and the reduction of the risk of osteoporotic fractures by reducing bone loss pursuant to Article 14 of Regulation (EC) No 1924/2006 (Available from:) http://www.efsa.europa.eu/fr/ efsajournal/doc/1609.pdf 2010 (Accessed 3 March 2011)
36. A. Endo The origin of the statins. 2004 Atheroscler. Suppl. 5 2004 125 130
37. I.L.S.I. Europe Scientific concepts of functional foods in Europe. Consensus document. Br. J. Nutr. 81 Suppl 1 1999 S1 S27
38. European Commission Regulation (EC) No 258/97 of the European Parliament and of the Council of 27 January 1997 concerning novel foods and novel food ingredients (Available from:) http://eurlex.europa.eu/LexUriServ/LexUriServ.do? uri=CELEX:31997R0258:EN:HTML 1997 (Accessed 3 March 2011)
39. European Commission White Paper on Food Safety - COM(1999) 719 (Available from:) http://ec.europa.eu/dgs/health-consumer/library/pub/pub06-en.pdf 2000 (Accessed 3 March 2011)
40. European Commission Directive 2000/13/EC of the European Parliament and of the Council of 20 March 2000 on the approximation of the laws of the Member States relating to the labelling, presentation and advertising of foodstuffs (Available from:) http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX: 32000L0013:EN:HTML 2000 (Accessed 3 March 2011)
41. European Commission Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (Available from:) http://eurlex.europa.eu/LexUriServ/ LexUriServ.do?uri=OJ:L:2001:311:0067:0128:EN:PDF 2001 (Accessed 3 March 2011)
42. European Commission Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (Available from:) http://ec.europa.eu/health/files/eudralex/vol-1/reg-2004-726-cons/ reg-2004-726-cons-en.pdf 2001 (Accessed 3 March 2011)
43. European Commission Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety (Available from:) http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2002:031:0001:0024: EN:PDF 2002 (Accessed 3 March 2011)
44. European Commission Proposal for a Regulation of the European Parliament and of the Council on nutrition and health claims made on foods (Available from:) http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=COM:2003:0424:FIN: EN:PDF 2003 (Accessed 3 March 2011)
45. European Commission Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use (Available from:) http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2004:136:0034:0057:EN: PDF 2004 (Accessed 3 March 2011)
46. European Commission Directive 2004/24/EC of 31 March 2004 amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human us (Available from:) http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2004:136:0085:0090:en: PDF 2004 (Accessed 3 March 2011)
47. European Commission Regulation (EC) No 1924/2006 of the European Parliament and the Council of 20 December 2006 on nutrition and health claims made on foods (Available from:) http://eurlex.europa.eu/LexUriServ/LexUriServ. do?uri=OJ:L:2006:404:0009:0025:EN:PDF 2006 (Accessed 3 March 2011)
48. European Commission Impact assessment for a regulation replacing regulation (EC) No 258/97 on novel foods and novel food ingredients (Available from:) http://ec.europa.eu/food/food/biotechnology/novelfood/nf-summary-ia-en. pdf 2008 (Accessed 3 March 2011)
49. European Commission Regulation (EC) No 983/2009 of 21 October 2009 on the authorisation and refusal of authorisation of certain health claims made on food and referring to the reduction of disease risk and to children's development and health (Available from:) http://eurlex.europa.eu/LexUriServ/ LexUriServ.do?uri=OJ:L:2009:277:0003:0012:EN:PDF 2009 (Accessed 3 March 2011)
50. European Commission Regulation (EC) No 1024/2009 of 29 October 2009 on the authorisation and refusal of authorisation of certain health claims made on food and referring to the reduction of disease risk and to children's development and health (Available from:) http://eurlex.europa.eu/LexUriServ/ LexUriServ.do?uri=OJ:L:2009:283:0022:0029:EN:PDF 2009 (Accessed 3 March 2011)
51. European Commission Decision of 17 December 2009 authorising a health claim on the effect of water-soluble tomato concentrate on platelet aggregation and granting the protection of proprietary data under Regulation (EC) No 1924/2006 of the European Parliament and of the Council (Available from:) http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2009:336:0055:0057:EN: PDF 2009 (Accessed 3 March 2011)
52. European Commission Regulation (EU) No 384/2010 of 5 May 2010 on the authorisation and refusal of authorisation of certain health claims made on foods and referring to the reduction of disease risk and to children's development and health (Available from:) http://eurlex.europa.eu/LexUriServ/ LexUriServ.do?uri=OJ:L:2010:113:0006:0010:EN:PDF 2010 (Accessed 3 March 2011)
53. European Commission Regulation (EU) No 957/2010 of 22 October 2010 on the authorisation and refusal of authorisation of certain health claims made on foods and referring to the reduction of disease risk and to children's development and health (Available from:) http://eurlex.europa.eu/LexUriServ/ LexUriServ.do?uri=OJ:L:2010:279:0013:0017:EN:PDF 2010 (Accessed 3 March 2011)
54. European Commission Europan Union Register of nutrition and health claims made on food - Authorized health claims (Available from:) http://ec.europa.eu/ food/food/labellingnutrition/claims/community-register/authorised-health-claims- en.htm 2011 (Accessed 3 March 2011)
55. S. Eussen, O. Klungel, J. Garssen, H. Verhagen, H. van Kranen, H. van Loveren, and C. Rompelberg Support of drug therapy using functional foods and dietary supplements: focus on statin therapy Br. J. Nutr. 103 2010 1260 1277
56. S.R. Eussen, N. de Jong, C.J. Rompelberg, J. Garssen, W.M. Verschuren, and O.H. Klungel Effects of the use of phytosterol/-stanol-enriched margarines on adherence to statin therapy Pharmacoepidemiol. Drug Saf. 19 2010 1225 1232
57. S.R. Eussen, C.J. Rompelberg, K.E. Andersson, O.H. Klungel, P. Hellstrand, R. Oste, H. van Kranen, and J. Garssen Simultaneous intake of oat bran and atorvastatin reduces their efficacy to lower lipid levels and atherosclerosis in LDLr-/- mice Pharmacol. Res. 64 2011 36 43
58. V. Franco, C.A. Polanczyk, N. Clausell, and L.E. Rohde Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols Am. J. Med. 116 2004 651 656 (Pubitemid 38581109)
59. H. Fransen, N. de Jong, M. Hendriksen, M. Mengelers, J. Castenmiller, J. Hoekstra, R. van Leeuwen, and H. Verhagen A tiered approach for risk-benefit assessment of foods Risk anal. 30 2010 808 816
60. S. Friso, and S. Choi Gene-nutrient interactions and DNA methylation J. Nutr. 132 2002 2382S 2387S (Pubitemid 34848112)
61. S. Garattini Evaluation of benefit-risk PharmacoEconomics 28 2010 981 986
62. C.J. Henry Functional foods Eur. J. Clin. Nutr. 64 2010 657 659
63. P. Hepburn, J. Howlett, H. Boeing, A. Cockburn, A. Constable, A. Davi, N. de Jong, B. Moseley, R. Oberdorfer, C. Robertson, J.M. Wal, and F. Samuels The application of post-market monitoring to novel foods Food Chem. Toxicol. 46 2008 9 33 (Pubitemid 350253107)
64. J. Hoekstra, A. Hart, A. Boobis, E. Claupein, A. Cockburn, A. Hunt, I. Knudsen, D. Richardson, B. Schilter, K. Schtte, P. Torgerson, H. Verhagen, B. Watzl, and A. Chiodini BRAFO tiered approach for benefit-risk assessment of foods Food Chem. Toxicol 2010 10.1016/j.fct.2010.05.049
65. J. Howlett Functional Foods From Science to Health and Claims ILSI Eur. Concise Monogr. Ser. 1-36 2008 (D/2008/10.996/1)
66. R. Huupponen, P. Seppl, and E. Iisalo Effect of guar gum, a fibre preparation, on digoxin and penicillin absorption in man Eur. J. Clin. Pharmacol. 26 1984 279 281 (Pubitemid 14130445)
67. J. Kaput Nutrigenomics research for personalized nutrition and medicine Curr. Opin. Biotechnol. 19 2008 110 120
68. M.B. Katan, and N.M. de Roos Public health. Toward evidence-based health claims for foods. Science 299 2003 206 207 (Pubitemid 36125195)
69. M.B. Katan, S.M. Grundy, P. Jones, M. Law, T. Miettinen, and R. Paoletti Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels Mayo Clin. Proc. 78 2003 965 978 (Pubitemid 36936128)
70. L. Kotilainen, R. Rajalahti, C. Ragasa, and E. Pehu Health Enhancing Foods. Opportunities for strengthening the sector in developing countries (Available from:) http://siteresources.worldbank.org/INTARD/Resources/Health- Enhacing-Foods-ARD-DP-30-final.pdf 2006 (Accessed 25 February 2011)
71. M. Kussmann, and L.B. Fay Nutrigenomics and personalized nutrition: science and concept Pers. Med. 5 2008 447 455
72. K. Lee, J. Ma, and G. Kuo Pharmacogenomics: bridging the gap between science and practice J. Am. Pharm. Assoc. 50 2010 e1 e14
73. H. Leroux Discovery of salicine J. Chim. Med. 6 1830 340 432
74. J.A. Lisman, and J.F.F. Lekkerkerker Four decades of European medicines regulation: what have they brought us? Int. J. Risk Saf. Med. 17 2005 73 79 (Pubitemid 41202235)
75. J.G. Mahdi, A.J. Mahdi, A.J. Mahdi, and I.D. Bowen The historical analysis of aspirin discovery, its relation to the willow tree and antiproliferative and anticancer potential Cell Prolif. 39 2006 147 155
76. J.S. Markowitz, J.L. Donovan, C.L. DeVane, R.M. Taylor, Y. Ruan, J.S. Wang, and K.D. Chavin Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme JAMA 290 2003 1500 1504 (Pubitemid 37430406)
77. P.N. Maton, and M.E. Burton Antacids revisited: a review of their clinical pharmacology and recommended therapeutic use Drugs 57 1999 855 870 (Pubitemid 29313197)
78. J.A. Milner Functional foods: the US perspective Am. J. Clin. Nutr. 71 2000 1654S 1659S (discussion 1674S-5S.) (Pubitemid 30396259)
79. J. Nadas, and D. Sun Anthracyclines as effective anticancer drugs Expert Opin. Drug Discovery 1 2006 549 568
80. A. Neuhofel, J. Wilton, J. Victory, L. Hejmanowsk, and G. Amsden Lack of bioequivalence of ciprofloxacin when administered with calcium-fortified orange juice: a new twist on an old interaction J. Clin. Pharmacol. 42 2002 461 466 (Pubitemid 34259781)
81. G. Pascal Safety impact-the risk/benefits of functional foods Eur. J. Nutr. 48 Suppl 1 2009 S33 S39
82. M.D. Patel, and P.D. Thompson Phytosterols and vascular disease Atherosclerosis 186 2006 12 19
83. Personalized Medicine Coalition The case for personalized medicine (Available from:) http://www.personalizedmedicinecoalition.org/about/about- personalized-medicine/the-casefor-personalized-medicine 2009 (Accessed 12 January 2011)
84. M. Pravenec, and T. Kurtz Molecular genetics of experimental hypertension and the metabolic syndrome: from gene pathways to new therapies Hypertension 49 2007 941 952 (Pubitemid 351688338)
85. W.O. Richter, B.G. Jacob, and P. Schwandt Interaction between fibre and lovastatin Lancet 338 1991 706
86. L.E. Rohde, M.C. de Assis, and E.R. Rabelo Dietary vitamin K intake and anticoagulation in elderly patients Curr. Opin. Clin. Nutr. Metab. Care 10 2007 1 5 (Pubitemid 44913869)
87. A.J. Scheen Drug-drug and food-drug pharmacokinetic interactions with new insulinotropic agents repaglinide and nateglinide Clin. Pharmacokinet. 46 2007 93 108 (Pubitemid 46193056)
88. C.R. Schneyer Calcium carbonate and reduction of levothyroxine efficacy JAMA 279 1998 750-750
89. B. Schwitters, G. Achanta, D. van der Vlies, H. Morisset, A. Bast, and J.C. Hanekamp The European regulation of food supplements and food fortification 2007 (ELM, 19.)
90. K. Szawlowska Risk assessment in the European Food Safety Regulation: who is to decide whose science is better? Commission v. France and Beyond... Ger. Law J. 5 2001 1259 1274
91. C. Taylor Regulatory frameworks for functional foods and dietary supplements Nutr. Rev. 62 2004 55 59 (Pubitemid 38327617)
92. R.S. Taylor, M.F. Drummond, G. Salkeld, and S.D. Sullivan Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle BMJ 329 2004 972 975 (Pubitemid 39422918)
93. M.J. Tijhuis, N. de Jong, M.V. Pohjola, H. Gunnlaugsdóttir, M. Hendriksen, J. Hoekstra, F. Holm, N. Kalogeras, O. Leino, F.X. van Leeuwen, J.M. Luteijn, S.H. Magnússon, G. Odekerken, C. Rompelberg, J.T. Tuomisto, O. Ueland, B.C. White, and H. Verhagen State of the art in benefit-risk analysis: food and nutrition 2011 Food Chem Toxicol DOI: 10.1016/j.fct.2011.06.010
94. U.S. Food and Drug Administration Dietary Supplements Health and Education Act of 1994 (Available from:) http://www.fda.gov/ RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/ SignificantAmendmentstotheFDCAct/ucm148003.htm 1994 (Accessed 12 January 2011)
95. U.S. Food and Drug Administration Federal Food, Drug, and Cosmetic Act (FD&C Act) (Available from:) http://www.fda.gov/RegulatoryInformation/ Legislation/FederalFoodDrugandCosmeticActFDCAct/default.htm 2005 (Accessed 12 January 2011)
96. U.S. Food and Drug Administration New Dietary Ingredients in Dietary Supplements - Background for Industry (Available from:) http://www.fda.gov/Food/ DietarySupplements/ucm109764.htm 2009 (Accessed 12 January 2011)
97. C. Ulbricht, W. Chao, D. Costa, E. Rusie-Seamon, W. Weissner, and J. Woods Clinical evidence of herb-drug interactions: a systematic review by the natural standard research collaboration Curr. Drug Metab. 9 2008 1063 1120
98. C.F. van Kreijl, A.G.A.C. Knaap, and J.M.A. van Raaij Our food, our health: healthy diet and safe food in the Netherlands 2006 189 213
99. H. Verhagen, J. te Boekhorst, L. Kamps, M.J. van Lieshout, H. Ploeger, D. Verreth, S. Salminen, and H. van Loveren Novel foods: an explorative study into their grey area Br. J. Nutr. 101 2009 1270 1277
100. H. Verhagen, E. Vos, S. Francl, M. Heinonen, and H. van Loveren Status of nutrition and health claims in Europe Arch. Biochem. Biophys. 501 2010 6 15
101. A. Wallace, J. Victory, and G. Amsden Lack of bioequivalence of gatifloxacin when coadministered with calcium-fortified orange juice in healthy volunteers J. Clin. Pharmacol. 43 2003 92 96 (Pubitemid 36015448)